학술논문
A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial☆
Document Type
Article
Author
Source
In Annals of Oncology March 2021 32(3):368-374
Subject
Language
ISSN
0923-7534